Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

SIMI VALLEY, California.—The White House has greenlit a plan to design and build a frigate domestically as part of its proposed “Golden Fleet,” Navy Secretary John Phelan announced at the Reagan ...

COLUMBUS, Ohio -- Ohio may start paying its small towns and villages to merge. A new bill at the statehouse would create a $25 million grant program to reward local governments that combine into one ...

Migrate the merge sort program from the ankehao-demo/COBOL-Examples repository to Java. The source file is located at merge_sort/merge_sort_test.cbl.

The free service gives instant access to air traffic control communications all over the world ...

Google's generative AI filmmaking program Flow has reached a milestone. The tech giant confirmed exclusively to CNET that Flow creators have produced over 100 million AI videos in the program. Thanks ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...

Recursion, a clinical-stage TechBio company, has successfully acquired Rallybio’s entire interest in their joint ENPP1 inhibitor program (REV102) aimed at treating hypophosphatasia (HPP), a rare ...

– Company Eligible to Receive Up to $25 Million, Including an Upfront Equity Payment of $7.5 Million – – Extends Rallybio Cash Runway to Mid-2027 – The REV102 program originated from a joint venture ...